1. Lipoprotein(a) and risk of myocardial infarction -- genetic epidemiologic evidence of causality.
- Author
-
Kamstrup, Pia R., Tybjærg-Hansen, Anne, and Nordestgaard, Børge G.
- Subjects
MYOCARDIAL infarction risk factors ,EPIDEMIOLOGY ,CARDIOLOGY ,GENETIC markers ,LIPOPROTEIN A ,POLYMERASE chain reaction ,GENETIC polymorphisms - Abstract
Elevated levels of lipoprotein(a) are associated with an increased risk of myocardial infarction. Our study aimed to test whether genetic data are consistent with this association being causal. Accordingly, we developed a high-throughput realtime PCR assay to genotype for the lipoprotein(a) kringle IV type 2 (KIV-2) repeat polymorphism in the LPA gene in > 40,000 individuals. The LPA KIV-2 genotype associated with plasma levels of lipoprotein(a) (trend p < 0.001), and the LPA KIV-2 genotype associated with risk of myocardial infarction (trend p < 0.001 to 0.03) in a manner consistent with its effect on plasma levels of lipoprotein(a). The association of LPA KIV-2 genotypes raising plasma levels of lipoprotein(a) with increased risk of myocardial infarction strongly supports a causal association of lipoprotein(a) with risk of myocardial infarction. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF